2438-03-1

Basic information

• Product Name: 2-Propylbenzoic acid
• Synonyms: 2-Propylbenzoic acid;Benzoic acid, 2-propyl-
• CAS NO: 2438-03-1
• Molecular Formula: C₁₀H₁₂O₂
• Molecular Weight: 164.2
• Mol File: 2438-03-1.mol
• Article Data: 15

Chemical Properties

• Melting Point: 58°C
• Boiling Point: 288.61°C (estimate)
• Appearance: /
• Density: 1.0020
• Refractive Index: 1.5232 (estimate)
• PKA: 4.15±0.36(Predicted)
• CAS DataBase Reference: 2-Propylbenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propylbenzoic acid(2438-03-1)
• EPA Substance Registry System: 2-Propylbenzoic acid(2438-03-1)

Safety Data

• Hazardous Substances Data: 2438-03-1(Hazardous Substances Data)

Upstream product

• 17475-41-1 3-ethylphthalide 
• 65946-52-3 1-Ethoxy-1-trimethylsilyloxy-1-buten 
• 108-90-7 chlorobenzene 
• 85-44-9 phthalic anhydride 
• 88-67-5 2-Iodobenzoic acid 
• 625-81-0 diisopropyl zinc 
• 38111-45-4 iso-propylzinc chloride 
• 119-64-2 tetralin 
• 610-97-9 o-iodo-methyl-benzoic acid 
• 1041642-22-1 2-(n-Propyl)-benzoesaeuremethylester 
• 61463-59-0 2-allyl benzoic acid methyl ester 
• 61658-90-0 3-ethylidenephthalide 
• 2360-45-4 2-propanoylbenzoic acid 
• 71885-44-4 4,5-dihydro-4,4-dimethyl-2-(2-methylphenyl)-2-oxazoline 

Downstream Products

• 1036390-52-9 C₂₁H₂₂N₂O₅ 
• 1036390-44-9 C₁₁H₁₃NO₄ 
• 177903-43-4 (2-Propyl-benzoyl)-phosphonic acid dimethyl ester 
• 1041642-22-1 2-(n-Propyl)-benzoesaeuremethylester 
• 63620-04-2 2-propyl-benzoyl chloride 
• 97567-64-1 2-n-Propylbenzonitrile 

Relevant articles and documents

MODIFIED PROTEINS AND PROTEIN DEGRADERS

Provided herein are compounds, pharmaceutical compositions, and methods for binding or degrading target proteins. Further provided herein are compounds having a DNA damage-binding protein 1 (DDB1) binding moiety. Some such embodiments include a linker. Some such embodiments include a target protein binding moiety. Further provided herein are ligand-DDB1 complexes. Further provided herein are in vivo modified DDB1 proteins.

6,5-BICYCLIC OCTAHYDROPYRROLOPYRIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to 6,5-bicyclic octahydropyrrolopyridine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

ETHYLDIAMINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to ethyldiamne compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.